Charles Schwab’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $813K | Sell |
313,738
-7,208
| -2% | -$18.7K | ﹤0.01% | 2965 |
|
|
2025
Q1 | $2.16M | Buy |
320,946
+5,414
| +2% | +$36.4K | ﹤0.01% | 2590 |
|
|
2024
Q4 | $2.14M | Buy |
315,532
+2,363
| +0.8% | +$16K | ﹤0.01% | 2656 |
|
|
2024
Q3 | $2.6M | Buy |
313,169
+15,543
| +5% | +$129K | ﹤0.01% | 2628 |
|
|
2024
Q2 | $1.89M | Sell |
297,626
-3,746
| -1% | -$23.8K | ﹤0.01% | 2725 |
|
|
2024
Q1 | $2.79M | Buy |
301,372
+12,015
| +4% | +$111K | ﹤0.01% | 2498 |
|
|
2023
Q4 | $3.69M | Buy |
289,357
+4,275
| +1% | +$54.5K | ﹤0.01% | 2431 |
|
|
2023
Q3 | $2.94M | Buy |
285,082
+8,183
| +3% | +$84.5K | ﹤0.01% | 2472 |
|
|
2023
Q2 | $3.63M | Buy |
276,899
+8,477
| +3% | +$111K | ﹤0.01% | 2362 |
|
|
2023
Q1 | $3M | Buy |
268,422
+18,586
| +7% | +$208K | ﹤0.01% | 2411 |
|
|
2022
Q4 | $2.11M | Sell |
249,836
-12,160
| -5% | -$103K | ﹤0.01% | 2559 |
|
|
2022
Q3 | $4.37M | Buy |
261,996
+13,014
| +5% | +$217K | ﹤0.01% | 2284 |
|
|
2022
Q2 | $3.67M | Buy |
248,982
+15,196
| +6% | +$224K | ﹤0.01% | 2320 |
|
|
2022
Q1 | $5.8M | Buy |
233,786
+5,547
| +2% | +$138K | ﹤0.01% | 2205 |
|
|
2021
Q4 | $7.32M | Buy |
228,239
+6,373
| +3% | +$204K | ﹤0.01% | 2160 |
|
|
2021
Q3 | $7.98M | Buy |
221,866
+117,710
| +113% | +$4.24M | ﹤0.01% | 2136 |
|
|
2021
Q2 | $4.6M | Buy |
104,156
+31,424
| +43% | +$1.39M | ﹤0.01% | 2393 |
|
|
2021
Q1 | $3.33M | Buy |
72,732
+1,691
| +2% | +$77.4K | ﹤0.01% | 2492 |
|
|
2020
Q4 | $4.9M | Buy |
+71,041
| New | +$4.9M | ﹤0.01% | 2230 |
|